Table 1.
History of development of ONSF for intracranial hypertension.
| References | Disease/model | ONSF related description |
|---|---|---|
| Moreau et al. (31) | Neuroretinitis | First report on ONSF. |
| Hayreh (32) | Animal model of intracranial hypertension | After ONSF, intracranial hypertensive papilledema was successfully eliminated. |
| Brourman et al. (33) | IIH (6 cases) | ONSF is the preferred way to improve vision in IIH patients. |
| Sergott et al. (34) | Sagittal sinus thrombosis (five cases) | With the first application of CVST, postoperative visual acuity has been improved, and the long-term prognosis is poor. It is suggested that the prognosis is closely related to the intervention time. |
| Acheson et al. (35) | Sagittal sinus and transverse sinus thrombosis (two cases) | 50% of patients' visual acuity improved, visual field improved. |
| Banta and Farris (36) | IIH (86 cases) | 97% of patients had stable or improved visual acuity and 88% had stable or improved visual field. |
| Cunha et al. (37) | Multiple venous thromboses in superior sagittal sinus, transverse sinus, and sigmoid sinus (one case) | Papilledema improved, vision deteriorated unceasingly. |
| Nithyanandam et al. (38) | Postpartum CVST (seven cases), other CVST (nine cases) | More than 80% of patients' visual acuity improved or stabilized. |
| Murdock et al. (22) | Factor V Leiden mutation, G20210A gene mutation, Factor XII deficiency, Decreased anticoagulant factor III and S protein, History of oral contraceptives CVST (one case) | Visual acuity and visual field improved; anticoagulation combined with ONSF is effective. |
| Moreau et al. (31) | CVST (seven cases) | ONSF has high security. |
| Elnahry et al. (39) | Antiphospholipid syndrome with CVST (one case) | Vision improved. |
| Bajin et al. (40) | IIH (56 cases) | The visual acuity and visual field of most of the operative and non-operative patients' eyes were improved, and the earlier the treatment, the better the effect. |